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Abstract
CRISPR/Cas9-mediated gene editing often generates founder generation (F0) mice that
exhibit somatic mosaicism in the targeted gene(s). It has been known that Fibroblast growth
factor 10 (Fgf10)-null mice exhibit limbless and lungless phenotypes, while intermediate
limb phenotypes (variable defective limbs) are observed in the Fgf10-CRISPR F0 mice.
However, how the lung phenotype in the Fgf10-mosaic mutants is related to the limb pheno-
type and genotype has not been investigated. In this study, we examined variable lung phe-
notypes in the Fgf10-targeted F0 mice to determine if the lung phenotype was correlated
with percentage of functional Fgf10 genotypes. Firstly, according to a previous report,
Fgf10-CRISPR F0 embryos on embryonic day 16.5 (E16.5) were classified into three types:
type I, no limb; type II, limb defect; and type III, normal limbs. Cartilage and bone staining
showed that limb truncations were observed in the girdle, (type I), stylopodial, or zeugopo-
dial region (type II). Deep sequencing of the Fgf10-mutant genomes revealed that the mean
proportion of codons that encode putative functional FGF10 was 8.3 ± 6.2% in type I, 25.3 ±
2.7% in type II, and 54.3 ± 9.5% in type III (mean ± standard error of the mean) mutants at
E16.5. Histological studies showed that almost all lung lobes were absent in type I embryos.
The accessory lung lobe was often absent in type II embryos with other lobes dysplastic. All
lung lobes formed in type III embryos. The number of terminal tubules was significantly
lower in type I and II embryos, but unchanged in type III embryos. To identify alveolar type 2
epithelial (AECII) cells, known to be reduced in the Fgf10-heterozygous mutant, immunos-
taining using anti-surfactant protein C (SPC) antibody was performed: In the E18.5 lungs,
the number of AECII was correlated to the percentage of functional Fgf10 genotypes. These
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data suggest the Fgf10 gene dose-related loss of the accessory lobe and decrease in the
number of alveolar type 2 epithelial cells in mouse lung. Since dysfunction of AECII cells has
been implicated in the pathogenesis of parenchymal lung diseases, the Fgf10-CRISPR F0
mouse would present an ideal experimental system to explore it.
Introduction
The recently developed CRISPR/Cas9 system provides a highly efficient means for editing the
genomes of model and non-model organisms. This powerful tool can help elucidate patho-
physiological mechanisms underlying various genetic diseases (reviewed in [1, 2]). CRISPR/
Cas9 promises the possibility of an ultimate cure for genetic diseases by enabling replacement
of mutated genes with normal alleles (reviewed in [3]); however, genome-edited founder mice
often exhibit somatic mosaicism in the targeted gene, meaning more than two mutated alleles
for that gene are mixed in the same mouse [4–6]. Such mosaicism may be undesirable when it
complicates phenotypic analysis [7]. However, mosaic mice may help the study of genes whose
constitutive mutations are lethal, or the study of interactions between mutant and normal cells
in the same individual [8]. Furthermore, recent DNA sequencing advances have enabled us to
identify genetic mosaicism even in phenotypically normal individuals, the pathological signifi-
cance of which is still unclear (reviewed in [9, 10]).
Previously, we reported that somatic mosaicism of a homeobox gene Pax6 mutation causes
variable eye phenotypes correlated with its gene dosage [11]. In this study, we focused on the
variable phenotypes of genome-edited Fgf10 founder generation (F0) mice. The Fgf10 gene is
required for limb and lung formation; Fgf10 null mutants suffer embryonic lethality at birth
due to lung agenesis [12, 13]. Recent studies have shown that a fraction of Fgf10 genome-edited
F0 mice exhibits typical limbless and lungless phenotypes, and that the severity of the limbless
phenotype depends on the Fgf10 mutation rate [7, 14, 15]. However, the lung phenotype has
not been described. In this study, we sought to determine the relationship between lung and
limb phenotypes, and correlation of these phenotypes to putative functional FGF10 dosage.
Materials and methods
Reagents and equipment used in this study are listed in S1 Table.
Mice and ethical statement
The animal experimental design was approved by the Committee of Animal Experiments of
Tokushima University, Tokushima, Japan, and by the Animal Care and Use Committee, Oka-
yama University, Okayama, Japan (Permit numbers: T27-16, T30-8, OKU-2017404,
OKU2018605). All surgeries were performed under reversible anesthesia with medetomidine-
midazolam-butorphanol and atipamezole, and all efforts were made to minimize suffering. In
vitro fertilized (IVF) eggs were prepared from male and female BDF1 (C57BL/6 x DBA2 F1)
mice as previously reported [14]. CRISPR/Cas9 genome editing was performed on one-cell
stage zygotes by microinjection (analysis on E16.5 embryos) with Cas9 mRNA and sgRNA tar-
geted at exon 3 of the Fgf10 gene according to Yasue et al. (2014) [14] (S1 Fig). After culturing
genome-edited zygotes until the two-cell stage, embryos were transferred to the uterine tube of
foster mice (Jcl: MCH (ICR) strain developed by CLEA Japan, Inc. (Tokyo, Japan); Jcl for
Japan clea, MCH for Multi-Cross Hybrid, and ICR for Institute of Cancer Research) and
allowed to develop until E16.5. To obtain E18.5 F0 embryos, Cas9 mRNA (100 ng/μL) and
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synthesized guide RNA (50 ng/μL) were electroporated into one-cell stage IVF eggs and fur-
ther manipulation of embryos was performed according to Hashimoto et al. (2016) [7].
CRISPR-control embryos were obtained by electroporation of medium only into IVF eggs
before processing them for sequencing and histological examination. To know developmental
variations, the weight of E18.5 embryos was measured with a standard electronic scale.
Enzyme mismatch cleavage assay
Approximately 25 μg genomic DNA were extracted from neck skin tissue (epidermis and der-
mis) of collected embryos using a Qiagen DNeasy Blood & Tissue Kit. The genomic region
encompassing the CRISPR/Cas9 target site was amplified by polymerase chain reaction (PCR)
using a primer set specific for the Fgf10 gene (S3A Fig, S1 Table) [14]. The amplicons were pro-
cessed for a mismatch cleavage assay using the Guide-it Mutation Detection Kit and the prod-
ucts were analyzed by 2% agarose gel electrophoresis (S3B Fig).
DNA sequencing
To verify the presence of the target site mutation, single bands of PCR amplicons of approxi-
mately 500 bp derived from the collected embryos at E16.5 (neck skin tissues) were subjected
to Sanger sequencing. The resulting DNA sequence waves were dissociated using a web tool
for TIDER data analysis available at https://tide.nki.nl [16].
Deep sequencing analysis using DNA extracted from neck skin, lung, and/or limb dermal
tissues (Table 1 for E18.5; neck skin only for E16.5 embryos in Table 3; neck skin only for addi-
tional E18.5 embryos in S3 Table) for the Fgf10 target site was performed according to the pre-
vious report on Illumina MiSeq system [17]. Briefly, the Fgf10 on-target site from each
individual embryo was amplified using custom barcode primers shown in S1 Table. Library
construction and sequencing were performed at the National Institute for Basic Biology
(NIBB, Japan) and Bioengineering Lab (Kanagawa, Japan). The pooled sequence data was
demultiplexed into each sample and analyzed subsequently using a web-based tool, CLiCKAR
[17].
Correction and calculation of putative somatic mutation rate in the case of
large insertions
PCR amplicons for deep sequencing were analyzed using TAPEStation 4200 system. When
larger DNA bands were detected above the main bands, their approximate molecular size was
recorded. “Peak Molarity” value for each DNA band was documented and the percentage of
large insertions was estimated by calculating the total value. The putative somatic mutation
rate for large insertions was calculated proportionally. In embryos #3 (type II, E16.5), #23
(type III, E18.5), #11_2 (type II, E18.5), and #22_2 (type III, E18.5), large insertions were
detected and corrected accordingly.
Cartilage and bone staining
After Cesarean dissection, E18.5 embryos, removed their skin and internal organs, were fixed
in 95% ethanol and processed for whole mount skeletal staining with Alcian blue 8GX and
Alizarin red S according to standard procedures [18].
Histology and analysis of terminal tubules
Hematoxylin-eosin (HE) staining was performed on mouse sections according to standard
procedures. Briefly, sections of 5 μm-thickness were made of the pectoral region of paraffin-
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embedded embryos and mounted on microscope slides. After deparaffinization and rehydra-
tion, sections were stained with Mayer’s hematoxylin solution and 0.125% eosin. Following
staining, sections were washed, dehydrated, and mounted with DPX. After HE staining, pho-
tos were taken with a 10x objective lens for each embryonic lung (n = 3 for each type, at E16.5)
(Fig 5E–5H) and tiled using ImageJ (https://imagej.nih.gov/ij/index.html)) (RRID:
SCR_003070). Terminal tubules were scored in the tiled full-field image (n = 1 for each
embryo). The area for the full-field was calculated by ImageJ and the number of terminal
tubules per mm2 were obtained and further analyzed statistically.
Immunohistochemistry and analysis of SPC-positive cells
Immunohistochemistry was performed on the 5 μm-thick deparaffinized sections using Imm-
PRESS Polymer Detection Kit for IHC. A rabbit polyclonal antibody against a synthetic pep-
tide fragment of human prosurfactant protein C (SPC) (within residues 1–100) was used at
1:5,000 dilution. The specificity of the antibody for AECIIs in the mouse lung has been vali-
dated [19]. The public identifier from the Antibody Registry is RRID: AB_10674024. After
immunohistochemistry, SPC-positive cells were scored in random portions of a section in
eight photomicrographs using a 40x objective lens. The total number of 6627 cells on average
was counted per sample. The results were presented as a ratio of the number of positive cells
per total number of cells [20]. This method has a limitation, in which as Fgf10 mutations have
been known to affect epithelial tube formation and branching [21] and therefore the number
of distal airway epithelial cells in total may be impacted, the accuracy of the data would be
ensured by normalizing AECII cell number to total epithelial cell number.
Microscopy and image processing
Images for sections were collected with a Nikon DS-Fi1 camera on a Leica DM5000B micro-
scope. Embryos, skeletons, and intestines were observed and imaged using a Leica DFC310FX
camera on a Leica M165FC stereomicroscope. Image manipulation such as levels and color
balance adjustments, made to some images, and assembly of figures were performed with
Adobe Photoshop CS6 Extended (RRID:SCR_014199).
Reverse transcription quantitative polymerase chain reaction (RT-qPCR)
Dissected embryonic lungs (E18.5) were immersed in RNAlater at 4˚C overnight and stored at
-80˚C until further use. Total RNA was extracted using NucleoZOL. Five micrograms of RNA
were reverse-transcribed to cDNA with FastGene cDNA Synthesis 5x ReadyMix. RT-qPCR was
performed in duplicate wells with BrightGreen 2X qPCR MasterMix-No Dye and LightCycler
Nano System using primers as shown in S4 Table. The PCR conditions employed were according
to the manufacturer’s protocol: 10 min at 95˚C for enzyme activation, 40 cycles of 15 sec at 95˚C
(denaturation) and 60 sec at 60˚C (annealing and extension). We performed no template negative
control experiments, as well as melting curve analysis according to manufacturer’s instructions.
Gene expression was normalized to a housekeeping gene, Glyceraldehyde-3-phosophate dehydro-
genase (Gapdh). Relative mRNA levels were determined by the comparative Ct method (Winer
et al. 1999). Error bars in S6 Fig show standard deviation and p values were calculated by Micro-
soft Excel (RRID:SCR_016137) and confirmed by WaveMetrics Igor Pro (RRID:SCR_000325).
Morphometric analysis of the cecum
Wild type (n = 3), type I (n = 4), and type II (n = 2) dissected intestines containing the cecum,
colons, and part of small intestines at E18.5 were photographed at the same magnification (S7
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Fig). The length of each cecum was measured using ImageJ. Briefly, multi-points were set
from the most proximal point abutting the small intestine and colon to the most distal cecum,
approximately 16 to 18 points in the case of wild type cecum. The sum of distance between
each point was regarded as the length of the cecum.
Statistical analysis
Significance was determined by one-way analysis of variance (ANOVA) (Fig 4B), Dunnett’s
test (Fig 5I), or two-tailed unpaired Student’s t-test (S5L and S7J Figs). Correlation analysis
was done by calculating correlation coefficient (Fig 6J–6L, S5M Fig). Chi-square test was used
for the comparison of deep sequencing data on DNA from two or three different tissues
(Table 4). Data were presented as mean ± standard error of the mean (SEM). Values of p<0.05
were considered significant otherwise stated. Data analysis was essentially performed using
Microsoft Excel except for Dunnett’s test, which was done using R (https://www.r-project.org)
(RRID:SCR_001905).
Results
Generation of Fgf10-CRISPR founder embryos and their limb skeletal
structures
To generate Fgf10-CRISPR mice, we used a single guide RNA (sgRNA) to target exon 3, as pre-
viously described (S1 Fig) [14]. According to Hashimoto and Takemoto (2015) [15], the resul-
tant Fgf10-CRISPR F0 embryos were classified by the limb phenotype into three types: type I,
no limb; type II, limb defect; and type III, normal limbs. Since skeletal pattern of these three
limb phenotypes has not been revealed, cartilage and bone staining was performed on E18.5
Fgf10-crispants (n = 4 for wild type; n = 11 for mutant embryos) (Table 2, Fig 1, S2 Fig). Nor-
mally, the appendicular skeleton consists of girdle (“pectoral” for forelimb and “pelvic” for
hindlimb) and limb elements. The skeletons of the fore- and hindlimbs consist of stylopod for
humerus/femur, zeugopod for the radius/ulna and tibia/fibula, and autopod for hand/foot
(S2I–S2K Fig). In type I embryos (n = 6), all limb bones were lost and remaining girdle bones
were affected to varying degrees (Fig 1A–1D; S2A–S2D Fig). The pectoral girdle consists of the
scapula and clavicle, while the pelvic girdle consists of the ilium, pubis, and ischium (S2I–S2K
Fig) (for review [22]). In four out of six type I embryos, the size of scapula was reduced and its
spine was not formed, indicating that the posterior blade was lost (Fig 1A). As for the pelvic
girdle, the ischial and pubic bones were lost, while iliac bones reduced bilaterally (Table 2 and
Fig 1B). In the remaining two embryos, the scapula was intact with a spine, while the pubis
and ischium were lost or reduced with the ilium intact bilaterally (Table 2 and Fig 1C and 1D;
S2C and S2D Fig). Thus, we regarded the latter phenotype as a type between I and II (type I/
II). In type II embryos (n = 2), all limb elements were lost in one or two appendages and in the
remaining appendages, limb truncations were observed at the stylopod or zeugopod level
(Table 2 and Fig 1E–1O; S2E and S2F Fig). In type III embryos examined (n = 3), all limb and
girdle bone structures were normal (Fig 1P–1R). These limb skeletal patterns indicated that
limb truncations were observed in the stylopodial, zeugopodial (type II), or pelvic region (type
I). Formation of the clavicle, and the superior part of the scapula and pelvic girdle were not
affected by lack of Fgf10 gene products.
Genomic analysis of Fgf10-CRISPR founder embryos
To prescreen mutations at the Fgf10 locus, we performed an enzyme mismatch cleavage assay
(S3A and S3B Fig) and Sanger sequencing with the use of DNA from neck skin tissues of the
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E16.5 embryos. We estimated mutation frequencies based on band intensities [23], and found
an embryo (type II, #4) with obvious limb defects but showed faint band intensities for
mutated DNA after endonuclease treatment (S3B Fig). Sanger sequencing indicated a mixed
genotype of wild type and a single nucleotide insertion in this embryo (S3C Fig).
Fig 1. Cartilage and bone staining to reveal limb skeletal structures. A-I, L-R, left or right lateral views of limb and girdle regions (at E18.5) are shown.
Cartilage is stained with Alcian blue and bone is stained with Alizarin red. A, B, type I #4_18 embryo. C, D, type I/II #46 embryo. E-I, type II #33 embryo. L-O,
type II #14 embryo. P-R, type III #12 embryo. J, K, Lateral views of type II #14 embryo are shown. Arrows in (K) show truncated limbs. au, autopod; f, femur;
fi, fibula; h, humerus; il, ilium; is, ischium; p, pubis; r, radius; sc, scapula; sp, spine; st, stylopod t, tibia; u, ulna; ze, zeugopod. Scale bars: 1 mm.
https://doi.org/10.1371/journal.pone.0240333.g001
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To get more accurate mutation frequencies, we performed deep sequencing of PCR ampli-
cons containing the Fgf10 target site by use of embryonic (E16.5) neck DNA. By multiple
Fig 2. Genomic analysis of the Fgf10-CRISPR F0 embryos at E16.5 as revealed by deep sequencing. The target nucleotide sequence is highlighted in yellow. Proto-
spacer adjacent motif sequence is shown in blue. Insertion and deletion sequences are shown in red.
https://doi.org/10.1371/journal.pone.0240333.g002
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amplicon analysis, we could distinguish between wild type, in-frame and frameshift mutations
(Fig 2). We also deduced amino acid sequences encoded by the targeted Fgf10 locus (Fig 3).
Among in-frame mutations, we found that codons that encode Lys196 and His201 were pre-
served or those that encode His201 alone were preserved as in #3, #5, and #9 embryos; both
residues are known to be indispensable for FGF receptor dimerization [24]. We calculated the
percentage of the gene sequence that still encodes putative functional FGF10 proteins with
both residues in each type of mutant at E16.5, finding 8.3 ± 6.2% for type I, 25.3 ± 2.7% for
Fig 3. Deduced amino acids for in-frame mutations after deep sequencing. Wild type (WT) sequences are shown on the top. The embryo (E16.5) number (#),
nucleotide number of small insertion (+) or deletion (-) (Indels) are shown on the left. Classified “types” are shown on the right. Amino acids corresponding to the guide
RNA sequence are underlined. Deleted and altered amino acids are indicated in red.
https://doi.org/10.1371/journal.pone.0240333.g003
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type II, and 54.3 ± 9.5% for type III, n = 3 for each type, mean ± SEM) (Table 3) (Fig 4A and
4B). In the case of E18.5 neck DNA, it was 3.4 ± 2.9% for type I (n = 3), 33% for type II (n = 1),
and 66.5 ± 8.8% for type III, respectively (n = 8) (Table 1).
To know whether genotyping results using DNA from different tissues were similar, we
performed deep sequencing on DNA extracted from lung and limb dermal tissues as well as
neck skin tissues of the E18.5 embryos (Table 1; S2 Table). We evaluated deep sequencing
results on type III embryos (n = 10) with Chi-square test (Table 4). We found that in 6
Fig 4. Schematic representation of genomic analysis of Fgf10-CRISPR F0 embryos at E16.5 by deep sequencing. A, percentage of total reads for the
Fgf10 crispants. wt, wild type Fgf10 target nucleotide sequence; in, in-frame mutations by small insertion or deletion; out, frameshift mutations. Among
in-frame mutations, the percentage of those that preserve the codons for Lys196 and His201 is shown in green, while the percentage that eliminate either
of them or both is shown in yellow. B, percentage of wild type and in-frame mutations in which nucleotides for both Lys196 and His201 are retained:
8.3 ± 6.2% for type I, 25.3 ± 2.7% for type II, and 54.3 ± 9.5% for type III. Data are presented as means ± SEM. �p<0.01 (p = 0.008).
https://doi.org/10.1371/journal.pone.0240333.g004
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embryos there was a significant difference in the frequencies of the functional Fgf10 genotypes
from the different tissues and in 4 embryos there was no significant difference in the frequen-
cies of the functional Fgf10 genotypes from the different tissues (Table 4).
Fig 5. Limb phenotypes and lung histology of Fgf10-CRISPR F0 embryos at E16.5. Representative embryos are shown for wild type (WT), type I (embryo
#7), type II (#3), and type III (#1). A–D, transverse section of the embryonic chest region. E–H, close-up of the embryonic lung (boxed area) shown in (A–D),
respectively. Asterisks show putative terminal tubules in the lung. I, the number of lung terminal tubules per unit area. In type I and type II embryos, there is
a significant decrease in the number compared with that of wild type. Data are presented as means ± SEM. Source data are available in Table 3. Ac, accessory
lobe; Ca, caudal lobe; Cr, cranial lobe; L, left lobe; Mi, middle lobe. Scale bars: 500 μm in (A–D), and 100 μm in (E–H).
https://doi.org/10.1371/journal.pone.0240333.g005
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Fig 6. Immunohistochemistry of the lung in type II and type III Fgf10-crispants and wild type embryos at E18.5.
Representative data are shown. Nuclei are stained with Hematoxylin. A-C, Localization of Surfactant protein C (SPC)
(alveolar type 2 epithelial cells) is indicated by brown staining. D-F, close-up of the boxed area shown in (A–C),
respectively. G-I, negative control, using normal rabbit IgG instead of anti-SPC antibody. Scale bars: 100 μm in (A-C);
50 μm in (D-I). J, K, the number of SPC-positive cells in type III embryos is correlated to the percentage of functional
PLOS ONE Lung of Fgf10-CRISPR mosaic mouse
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Analysis of lung phenotypes
We next examined the lung histology of Fgf10-mosaic F0 embryos on E16.5 (Table 3, Fig 5, S4
Fig). In the normal mouse lung, there are five lung lobes, four on the right (cranial, middle,
caudal, and accessory) and one on the left (Fig 5A). The lung histology of type I embryos dem-
onstrated either the absence of all lobes (two of three embryos) or only the presence of a resid-
ual lobe (one of three) (Fig 5B). We found that the accessory lobe was absent in two out of
three type II embryos, and that either middle or caudal lobe was additionally absent or hypo-
plastic (Fig 5C). In type III embryos, all five lung lobes were present (Fig 5D). In E18.5 type II
embryos, the accessory lung lobe was absent from all three embryos examined (embryo #11_2,
24_2, 25_2; S5I–S5K Fig).
Mouse lung development is divided into five stages, namely embryonic, pseudoglandular
(E9.5 to 16.5), canalicular (E16.5 to 17.5), saccular (E17.5 to P5), and alveolar (P5 to P28) [25].
At E16.5, after branching morphogenesis the lung is in the transition of pseudoglandular to
canalicular stage. We found that the number of terminal tubules was significantly decreased in
type I and II residual lungs (Fig 5F, 5G and 5I), but not significantly altered in type III lungs
(Fig 5H and 5I), compared with wild type (Fig 5E and 5I). By E18.5, the lung enters the saccu-
lar stage and cuboidal cells that produce surfactant protein C (SPC), i.e. alveolar type 2 epithe-
lial (AECII) cells, differentiate on the wall of the developing airway space. Since AECII cell
differentiation is perturbed in the Fgf10-heterozygous lung [26, 27], we performed
Fgf10 genotypes in limb (J) or neck DNA (K). L, the number of SPC-positive cells in type III embryos is not to
correlated to their weight (K). Source data for (J-L) are available in Table 1. M, Schematic drawings to show percentage
of total reads for the type III Fgf10 crispants. wt, wild type Fgf10 target nucleotide sequence; in, in-frame mutations by
small insertion or deletion; out, out-of-frame mutations. Among in-frame mutations, the percentage of those that
preserve the codons for Lys196 and His201 is shown in green, while the percentage that eliminate either of them is
shown in yellow.
https://doi.org/10.1371/journal.pone.0240333.g006
Table 4. Chi-square test for genotyping results of DNA derived from different tissues.
Embryo No. Type Observed frequencies Expected frequencies (EF) p-
value
#2 Wild
type
Neck Lung Limb Total Neck Lung Limb Total N.A.
Wt 4877 8760 58889 72526 Wt 4893.8 8757.8 58874 72526
Out 18 0 0 18 Out 0.0675 2.1736 15 18
Total 4895 8760 58889 72544 Total 4895 8760 58889 72544
EF: less than 5
#11 III Neck Lung Limb Total Neck Lung Limb Total 3E-29
Wt 6686 12893 18549 38128 Wt 6289.8 13430 18408 38128
Out 3182 8178 10331 21691 Out 3578.2 7640.6 10472 21691
Total 9868 21071 28880 59819 Total 9868 21071 28880 59819
#12 III Lung Limb Total Lung Limb Total 0.7515
Wt 706 19627 20333 Wt 710.8 19622 20333
Out 364 9911 10275 Out 359.2 9915.8 10275
Total 1070 29538 30608 Total 1070 29538 30608
#13 III Lung Limb Total Lung Limb Total 4E-05
Wt 4203 45331 49534 Wt 4304.1 45230 49534
Out 886 8147 9033 Out 784.89 8248.1 9033
Total 5089 53478 58567 Total 5089 53478 58567
#15 III Neck Lung Limb Total Neck Lung Limb Total 3E-11
(Continued)
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Table 4. (Continued)
Embryo No. Type Observed frequencies Expected frequencies (EF) p-
value
Wt 7295 20266 22243 49804 Wt 6952.3 20313 22539 49804
W/o &
Out
4908 15388 17318 37614 Out 5250.7 15341 17022 37614
Total 12203 35654 39561 87418 Total 12203 35654 39561 87418
#16 III Lung Limb Total Lung Limb Total N.A.
Wt 15698 38223 53921 Wt 15698 38223 53921
Out 0 0 0 Out 0 0 0
Total 15698 38223 53921 Total 15698 38223 53921
EF: less than 5
#17 III Lung Limb Total Lung Limb Total 3E-50
Wt 3441 21706 25147 Wt 3505.1 21642 25147
In (w) 2869 13857 16726 In
(w)
2331.3 14395 16726
Out 2690 20007 22697 Out 3163.6 19533 22697
Total 9000 55570 64570 Total 9000 55570 64570
#20 III Neck Limb Total Neck Limb Total 2E-10
Wt 29282 5549 34831 Wt 29043 5787.9 34831
In (w) 11875 2653 14528 In
(w)
12114 2414.1 14528
Total 41157 8202 49359 Total 41157 8202 49359
#21 III Neck Limb Total Neck Limb Total 0.176
Wt 23077 10726 33803 Wt 23153 10650 33803
Out 17464 7923 25387 Out 17388 7998.7 25387
Total 40541 18649 59190 Total 40541 18649 59190
#22 III Neck Limb Total Neck Limb Total 0.2711
Wt 2653 963 3616 Wt 2677.4 938.58 3616
Out 6521 2253 8774 Out 6496.6 2277.4 8774
Total 9174 3216 12390 Total 9174 3216 12390
#23 III Neck Limb Total Neck Limb Total N.A.
�including large
deletion
Wt 82324 1146 83470 Wt 82291 1178.5 83470
Out� 0 33 33 Out� 32.534 0.4659 33
Total 82324 1179 83503 Total 82324 1179 83503
EF: less than 5
#24 III Neck Limb Total Neck Limb Total 1E-26
Wt 8862 2633 11495 Wt 9094.9 2400.1 11495
Out 3268 568 3836 Out 3035.1 800.93 3836
Total 12130 3201 15331 Total 12130 3201 15331
#25 III Neck Limb Total Neck Limb Total 0.1551
��including
large insertion
In(w) 12665 10417 23082 In(w) 12582 10500 23082
Out�� 18415 15520 33935 Out�� 18498 15437 33935
Total 31080 25937 57017 Total 31080 25937 57017
The number of sequence reads in deep sequencing is shown in contingency tables for observed frequencies. Wt, wild
type Fgf10 genotype; Out, frameshift mutations in the Fgf10 gene; W/o & Out, in-frame mutation without
nucleotides encoding Lys196 and/or His201 plus frameshift mutations in the Fgf10 gene; In (w), in-frame mutations
with nucleotides encoding Lys196 and His201; In (w/o), in-frame mutations without nucleotides encoding Lys196
and/or His201. When p-values <0.05, there is statistically significant difference in the Fgf10 genotypes of the
different tissues.
https://doi.org/10.1371/journal.pone.0240333.t004
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immunohistochemistry on E18.5 lung sections to detect AECII. We counted the number of
SPC-positive cells in lungs of type III embryos and examined whether it was correlated to the
percentage of functional Fgf10 genotype. Representative data of immunostaining for type III
lungs are shown (Fig 6B and 6E) along with those for type II lungs (Fig 6A and 6D) and posi-
tive/negative controls (Fig 6C, 6F and 6G–6I). We found that the number of SPC-positive cells
in lungs of type III embryos was correlated to the percentage of functional Fgf10 genotype (Fig
6J, correlation coefficient is 0.909 for limb DNA; Fig 6K, 0.924 for neck DNA). Since the delay
in development can be caused by variation between embryos even from a same litter due to
crowding in the uterus, we also examined whether the number of SPC-positive cells was corre-
lated to the weight of each embryo, as an index for developmental stage (Table 1). It seemed
that there was no correlation between them (Fig 6L; correlation coefficient is 0.301).
On the other hand, since it was reported that the mesenchymal FGF10 is also important for
proper mesenchymal lineage formation during lung development as revealed by Fgf10-hypo-
morphic lungs [20, 28], we examined expression of mesenchymal and its related marker genes
[29] in type III lungs at E18.5 by quantitative PCR (Table 1, S4 Table). However, we could not
detect a significant decrease in expression of these genes (S6 Fig), possibly because the percent-
age for functional Fgf10 genotypes was too high to mimic a Fgf10-hypomorphic phenotype in
lung mesenchymal lineage formation (61.19% in #11, 65.98% in #12, and 70.11% in #17
embryos). This expression analysis should be further clarified on earlier stage lungs, and in
those which have more loss-of-function mutations in the Fgf10 gene.
Discussion
Fgf10 genome edited F0 mice are classified into three limb phenotypes: no limb (type I), limb
defect (type II), and normal limbs (type III). In this study, we first examined appendicular skel-
etal patterns of the Fgf10 mosaic mutant mice by cartilage and bone staining. We found that
varying degrees of limb and girdle bone truncations were observed in type I and type II
embryos. We next estimated the rate of putative functional Fgf10 genotypes in each mutant
type and the mean percentage for type II embryos is 25.3 ± 2.7 by deep sequencing of neck
DNA. Comparison of deep sequencing results on DNA from different tissues (neck, lung, and
limb dermis) revealed that in half of the embryos the rate of putative functional Fgf10 geno-
types were significantly varied between the three DNA. Lung phenotypes were examined on
two embryonic stages, E16.5 and E18.5. In type II embryos, the accessory lobe was lost and the
number of terminal tubules was significantly reduced. In type II and “normal limb (type III)”
embryos, the number of alveolar type 2 cells, immunostained by anti-surfactant C protein, was
correlated with the rate of putative functional Fgf10 genotypes.
Truncation patterns of girdle and limb bones in Fgf10-mosaic mutants
Skeletal staining in this study revealed that in type II embryos, limb bone structures are trun-
cated in more distal structures rather than forming a miniature of whole limb and girdle struc-
tures. Also, in the mutants, the zeugopodial element consists of one ulna- or tibia-like bone:
This pattern is different from those after extirpation of apical ectodermal ridge in chicken limb
buds, where both zeugopod bones are truncated [30]. Although the number of type II embryos
examined in this study is only two and therefore further studies are needed, a reduced number
of Fgf10-expressing cells in the mosaic mutants does not seem to know the morphological pat-
tern to be formed. Looking the expression of zeugopod patterning genes could help to eluci-
date the underlying mechanisms.
Regarding girdle bones, it has been known that the posterior (inferior) half of the scapula is
absent and most of the pelvic structures is lacking in Fgf10-null embryos [12, 13]. This study
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showed that in type I/II Fgf10-mosaic mutants the posterior scapula with the spine retained. In
the mouse, while the pelvic girdle and most of the scapular blade derives solely from the lateral
plate mesoderm (LPM), the medial edge of the blade arises from dermomyotome cells and the
neural crest cells contribute to the scapular spine [31–33]. Thus, it is likely that a reduced num-
ber of Fgf10-expressing cells in the LPM and neural crest cells [34] contributed to the forma-
tion of the posterior (inferior) scapula in type I/II embryos. In the case of pelvic girdle, a
reduced number of Fgf10-expressing cells in the LPM contributed to the formation of the infe-
rior pelvic structures in type I/II embryos.
Fgf10 mutation rate may not be identical in different tissues
Here we showed that there is a correlation between limb phenotypes, lung phenotypes, and
overall defective mutation rate in Fgf10-CRISPR knockout F0 mice. It has been shown that
even if CRISPR-genome editing materials are introduced into fertilized eggs at the one-cell
stage, mosaicism in the target genotype is caused under certain experimental conditions until
the target sequences are mutated [6, 7]. During the early embryonic stage, mutated cells and
non-mutated cells are intermingled and distributed to lung and limb primordia proportionally
[35], which we believe contributes to the correlation between limb and lung phenotypes. How-
ever, statistical analysis on deep sequencing data of the genotypes shows in more than half
cases there is a significant difference of the defective mutation rate in DNA from different tis-
sues. In this study, we could not identify the reason why there were differences in the rate of
the functional Fgf10 genotypes. In some developmental settings, Fgf10-expressing normal cells
might have a growth advantage than Fgf10-deficient cells, which should be further explored in
the next studies [10].
Fgf10-CRISPR F0 mice possess degrees of lung dysgenesis that correlate
with putative functional FGF10 dosage
Accessory lobe formation was firstly impaired due to reduction in putative functional FGF10
dosage. Ramasamy et al. (2007) reported that Fgf10-hypomorphic mice, in which Fgf10 expres-
sion is reduced by 27%, compared with Fgf10-heterozygous mutants, lack accessory lobe for-
mation [20]. Since Fgf10 expression is highest in the mesenchyme of the accessory lobe on
E11.5 and persists as such until at least E18.5 [21, 29], high Fgf10 dosage was believed to be
required for accessory lobe formation. Our result shows that more than 25.3 ± 2.7% (from the
analysis of E16.5 embryos) of functional Fgf10 gene product is required for accessory lobe for-
mation. Since reduction or loss of accessory lobe formation has been observed in loss-of-func-
tion mutants of Gli3, Fog2, and Gata4 [36–38], FGF10 signaling may be related to the
expression of these transcription factors during accessory lobe formation.
Lineage-tracing analysis of Fgf10-expressing cells during mouse lung development has
revealed that there are two waves of Fgf10 expression; the first begins from E11.5 and the sec-
ond from E15.5 [29]. We think that a reduction in the latter cells would cause the decrease in
the number of terminal tubules in type I and type II Fgf10-CRISPR F0 embryos. A recent study
has shown that AECII as well as AECI independent progenitors are present at E13.5 as
revealed by single cell RNA sequencing analysis [39]. By the saccular stage, the lung mesen-
chyme surrounding the epithelium becomes thinner and cuboidal AECII cells, characterized
by the production of surfactant proteins, begin to differentiate (summarized in [40]). The
number of AECII cells is found to be lower in the Fgf10-heterozygous lung [26, 27], which is
similar to our result in type III Fgf10-mosaic mice. Taken together, Fgf10 expression levels reg-
ulate the number of alveolar type 2 epithelial cells in mouse lung in somewhat dose-dependent
manner.
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Regarding FGF10 dosage, the Fgf10-hypomorphic mouse aforementioned [20, 28] has also
clarified that higher FGF10 dosage is required for full development of colonic crypts [41]. Our
preliminary observation (S7 Fig) showed that in type I embryos the length of the cecum was
significantly shorter than the wild type and there was an atresia of the colon as reported in the
Fgf10-null mutants [41, 42]. The length of the blind colon varied depending upon the embryos
(S7D–S7G Fig), suggesting a correlation with their FGF10 dosage.
Fgf10-CRISPR F0 mice can serve as a series of lung disease models
Volckaert et al. (2013) reported that lung branching morphogenesis does not require localized
Fgf10 expression in the distal mesenchyme, because ubiquitous Fgf10 overexpression can
induce lung formation in Fgf10 knockout mice [43]. Furthermore, Fgf10 expression after lung
initiation is required for branching and proximal-distal differentiation by regulating Sox2/9
expression in the epithelium [43]. Our result also supports this property of Fgf10 as the num-
ber of terminal tubules decreased in the Fgf10-mosaic mutants where functional FGF10 dosage
is reduced.
Recent papers have reported that mutations and single nucleotide polymorphisms (SNPs)
in the Fgf10 gene are correlated with human lung disease (reviewed in [44]). For example, the
absence of the right medial-basal airway is associated with a type of chronic obstructive pulmo-
nary diseases and two types of SNPs are found within the same intron of Fgf10 in those cohorts
[45]. Although some molecular and cellular differences have been identified between mouse
and human lungs (reviewed in [46]), the F0 mice generated by CRISPR/Cas9-mediated Fgf10
gene editing can become a model animal to study the pathophysiology of human pulmonary
hypoplasia and related chronic lung diseases that may be rooted in the developmental stage as
recently postulated [47]).
Supporting information
S1 Table. List of reagents and equipment used in this study.
(DOCX)
S2 Table. Summary of deep sequencing data on DNA from different tissues of E18.5
embryos. The percentage of sequence reads for each genotype category is shown in contin-
gency tables. Wt, wild type Fgf10 genotype; In, in-frame mutations in the Fgf10 gene; Out,
frameshift mutations in the Fgf10 gene; N.D., not done; N.A., not applicable. p-values of Chi-
square test (see Table 4) are shown for reference.
(DOCX)
S3 Table. Summary of type II and type III embryos examined for E18.5 lungs by immuno-
histochemistry, shown in Fig 6 and S5 Fig. �Approximately 295- (#11_2) and 79- (#22_2) bp
insertion were detected by microchip electrophoresis and the number of sequence reads in
deep sequencing was corrected accordingly (see Materials and methods). N.D., not deter-
mined.
(DOCX)
S4 Table. Primers used for quantitative PCR (qPCR) analysis.
(DOCX)
S1 Fig. Structure of the mouse Fgf10 gene indicating the target sites for CRISPR/Cas9 sys-
tem.
(TIF)
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S2 Fig. Cartilage and bone staining to reveal skeletal structures. A-H, whole mount staining.
Left (A, C, E, G) and right (B, D, F, H) lateral views are shown. Arrows show truncated limb
and girdle bones. I-K, wild type skeletal structures, showing scapula and forelimb (I), hindlimb
(J), and pelvic girdle (K). au, autopod; f, femur; fi, fibula; h, humerus; il, ilium; is, ischium; p,
pubis; r, radius; sc, scapula; sp, spine; st, stylopod; t, tibia; u, ulna; ze, zeugopod. Scale bars: 1
mm.
(TIF)
S3 Fig. Mismatch cleavage assay. A, PCR primers were designed in the upstream region of
the exon 3 and in the exon 3, giving rise to a PCR amplicon size of 501 bp. DNA fragments of
309 bp and 192 bp are generated by the Resolvase when the Fgf10 genome has been cleaved by
Cas9 and non-homologous end joining has been achieved. B, Electrophoresis of the enzyme-
treated mouse genomic DNA from the Fgf10-CRISPR F0 embryonic necks. The DNA ladder
for DNA size reference and a result of DNA from a wild type (WT) mouse are shown on the
left. Three DNA fragments of approximately 500 bp (▼), 300 bp (5 in gray), and 200 bp (5)
are seen in all the lanes except for the wild type and #4 lanes. In embryo #3, an extra band for
large insertion (328 base) is shown (see Fig 2). C, Genomic analysis of the #4 embryo as
revealed by Sanger sequencing. Deduced amino acid sequences are also shown. Lys-196 and
His-201 are highlighted in yellow and green, respectively. Altered amino acids are indicated in
red. Asterisks indicate stop codons.
(TIF)
S4 Fig. Limb phenotypes and lung histology of all embryos examined at E16.5 as summa-
rized in Table 3. Scale bars: 500 μm.
(TIF)
S5 Fig. Limb phenotypes, lung histology, and the number of SPC-positive cells per total
cell number of type II and type III embryos at E18.5. Source data for (L, M) are available in
S3 Table. Lateral views of type II (A-F), and type III (G, H) embryos at E18.5. Arrowheads
show limb defects. (I-K) In all three type II embryos, the accessory lobe was lost. In embryo
#24_2, (J), the middle lobe (Mi) was also undetectable. Data in (L) are presented as
means ± SEM. (M) In these embryos, the number of SPC-positive cells was more correlated to
the percentage of wild type Fgf10 genotype (correlation coefficient [R] was 0.728 for neck
DNA) than that including in-frame mutations with Lys196 and His201 retained (R = 0.334).
Scale bar: 2 mm (A-H).
(TIF)
S6 Fig. Quantitative PCR analysis for mRNA expression of mesenchymal and its related
marker genes in wild type and type III lungs at E18.5.
(TIF)
S7 Fig. Cecum and colons of the wild type and Fgf10-CRISPR F0 (type I and type II)
embryos at E18.5. A-C, wild type (Wt) cecum (c), colon, and small intestine (si) are shown
from three embryos examined. Ileum and colon were cut at dissection. D-G, type I cecum is
reduced compared with the wild type. Whether the cecum epithelium is absent or not cannot
be identified from these photos. Type I embryos show an atresia of the colon, but the length
varies depending upon the embryos. H-I, type II embryos examined (n = 2) do not exhibit a
reduced cecum or an atresia of the colon. The colons presented here were cut as distally as pos-
sible. J, the approximate length of the cecum. The length of type I cecum is significantly
decreased compared with the wild type. The length of two type II embryos examined is also
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shown for reference. Scale bar: 1 mm (in A for all to scale).
(TIF)
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